Toxic nephropathies.
The general topic of kidney damage produced by drugs and toxins is introduced, emphasizing its clinical importance in critically ill patients. Specific toxins are then examined in detail with respect to the mechanisms of toxicity, clinical features, and management.
Sondheimer
J H
JH
Wayne State University School of Medicine, Detroit, Michigan.
Migdal
S D
SD
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D019855:Ethylene Glycol; D005026:Ethylene Glycols / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010860:Pigments, Biological / Q000009:adverse effects; D015275:Tumor Lysis Syndrome / Q000150:complications
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D003287:Contrast Media; D005026:Ethylene Glycols; D010860:Pigments, Biological; D019855:Ethylene Glycol